ASO Author Reflections: Pathologic Response Ratio (PRR) in CRS and HIPEC for Peritoneal Metastasis from Colorectal Cancer

Ann Surg Oncol. 2021 Dec;28(13):9148-9149. doi: 10.1245/s10434-021-10369-4. Epub 2021 Jun 27.

Authors

Eyal Mor¹, Shachar Laks², Aviram Nissan², Mohammad Adileh²

Affiliations

¹ The Department of General and Oncological Surgery - Surgery C, Sheba Medical Center, Affiliated with the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. eyal_more@hotmail.com.
² The Department of General and Oncological Surgery - Surgery C, Sheba Medical Center, Affiliated with the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

PMID: 34180017
DOI: 10.1245/s10434-021-10369-4

No abstract available

MeSH terms

Chemotherapy, Cancer, Regional Perfusion
Colorectal Neoplasms* / drug therapy
Combined Modality Therapy
Cytoreduction Surgical Procedures
Humans
Hyperthermia, Induced*
Hyperthermic Intraperitoneal Chemotherapy
Peritoneal Neoplasms* / drug therapy